$Merck & Co (MRK.US)$ Merck & Co., a pharmaceutical company ...
$Merck & Co (MRK.US)$
Merck & Co., a pharmaceutical company in the United States, has released the latest research data on its oral medication for the 2019 coronavirus, indicating that the drug only has an efficacy of 30% in reducing the risk of hospitalization or death for patients. This latest data from Merck & Co. is much lower than the 50% effectiveness announced in October. The company released this data before the Food and Drug Administration (FDA) issued an analysis report on the safety of the drug. After the FDA published its preliminary analysis, it stated that Merck & Co.'s oral medication is effective in treating the coronavirus, but experts believe that it is not suitable for pregnant women. The FDA's experts will hold a meeting next week to discuss whether to recommend emergency use authorization for this medication.
Merck & Co., a pharmaceutical company in the United States, has released the latest research data on its oral medication for the 2019 coronavirus, indicating that the drug only has an efficacy of 30% in reducing the risk of hospitalization or death for patients. This latest data from Merck & Co. is much lower than the 50% effectiveness announced in October. The company released this data before the Food and Drug Administration (FDA) issued an analysis report on the safety of the drug. After the FDA published its preliminary analysis, it stated that Merck & Co.'s oral medication is effective in treating the coronavirus, but experts believe that it is not suitable for pregnant women. The FDA's experts will hold a meeting next week to discuss whether to recommend emergency use authorization for this medication.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
